8.2 Health & Care

An ageing population, an increasing number of chronic conditions, the need for specialized care and pressure on budgets have significantly impacted the health care sector.

Top

A necessary cost and efficiency consciousness is leading hospitals and related services to optimize their care offerings. This includes specialization in certain areas and locations, or flexible hospital care systems (short-stay or day hospitalization) supplemented with outpatient care. In the biotechnology sphere, researchers are continuously working on new technology, often with groundbreaking results. Medical technology, too, is changing.

Responding to these developments, the Health & Care platform had a particularly active year with 4 new partnerships: Biom'Up (French manufacturer of biosurgery devices, www.biomup.com) raised EUR 31.3 million from Gimv and other life sciences investors; a EUR 12.5 million investment in the further growth of Equipe Zorgbedrijven (Dutch group of specialist clinics at 11 locations, www.equipezorgbedrijven.nl), a shareholding in Benedenti (one of the largest multidisciplinary group dental practices in Flanders, www.benedenti.be, cf. below); and Topas Therapeutics (German biopharmaceutical company with unique technology. for treating antigen-specific immune tolerance).

The team also undertook 2 divestments: Acertys Group (a leading provider of total medical equipment solutions to hospitals and medical professionals in the Benelux, www.acertys.com), was sold to Belgian industrial partner Duo-Med, and Gimv's interest in Prosonix (pharmaceutical company specializing in innovative respiratory drugs, UK, www.prosonix.co.uk) was sold to Circassia Pharmaceuticals PLC, a specialty biopharmaceutical company listed on the London Stock Exchange (Ticker: CIR.L).

Finally, there were several investment transactions in the existing portfolio: Almaviva Santé (France, group of specialized private hospitals, www.almaviva-sante.fr) moved into a new dimension by merging with Clinique Arago and the Domus Cliniques private hospitals group. And JenaValve (Germany, specializing in developing transcatheter aortic valves that can be inserted via the groin or an incision between two ribs, www.jenavalve.de) raised USD 26.5 million from an investor syndicate.

Overview Health & Care portfolio

As of end-March 2016, the Health & Care team had 11 portfolio companies representing EUR 94 million.

CompanyActivityCountry
AgroSavfeDevelopment of innovative formulations of crop production productsBelgium
Almaviva SantéGroup of 22 specialized private clinics France
BenedentiMultidisciplinary group practice - dental careBelgium
Biom'UpMedical devices for biosurgeryFrance
ComplixBiopharmaceutical company developing a pipeline of therapeutics mainly focused on oncology and autoimmunityBelgium
Equipe ZorgbedrijvenGroup of specialised clinicsthe Netherlands
EuroceptOffers a unique combination of specialty pharma and medical homecarethe Netherlands
JenaValveDevelopment of transcatheter aortic valvesGermany
MultiplicomMolecular diagnosticsBelgium
Oldelft UltrasoundHigh-tech medical diagnosticsthe Netherlands
Topas TherapeuticsBiopharma company that developed a unique technology for the induction of antigen-specific immune toleranceGermany
CompanyActivityCountry
AgroSavfeDevelopment of innovative formulations of crop production productsBelgium
Almaviva SantéGroup of 22 specialized private clinics France
BenedentiMultidisciplinary group practice - dental careBelgium
Biom'UpMedical devices for biosurgeryFrance
ComplixBiopharmaceutical company developing a pipeline of therapeutics mainly focused on oncology and autoimmunityBelgium
Equipe ZorgbedrijvenGroup of specialised clinicsthe Netherlands
EuroceptOffers a unique combination of specialty pharma and medical homecarethe Netherlands
JenaValveDevelopment of transcatheter aortic valvesGermany
MultiplicomMolecular diagnosticsBelgium
Oldelft UltrasoundHigh-tech medical diagnosticsthe Netherlands
Topas TherapeuticsBiopharma company that developed a unique technology for the induction of antigen-specific immune toleranceGermany

Top

Benedenti - Multidisciplinary group dental practices - Belgium - Gimv took a minority interest in 2015

Benedenti

"With support from Gimv, Benedenti wants to roll out modern, multidisciplinary group practice for dental care across Flanders."

Profile
Benedenti is one of the largest multidisciplinary group practices in Flanders. With outlets in Herentals, Berlaar and Vlimmeren, it treats many thousand patients a year. Benedenti has 48 employees, including 16 dentists each with their own specialty. The group wants to be known as a one-stop-shop for high-quality dental care for the whole family, with all specialties under one roof, including general dentistry, orthodontics, endodontics, periodontics, implantology and aesthetic dentistry. In this way, dentists can focus 100% on the medical aspect, supported by practice managers and dental assistants.

Investment context
Dental care in Flanders faces many challenges in the coming years: ageing dental corps, shortage of new graduate dentists, numerous technical and scientific developments, and evolving expectations of patients, young dentists and society as a whole.

Growth strategy
Working with Gimv, Benedenti wants to roll out the principle of the modern, multi-disciplinary group practice for dental care throughout Flanders. This calls for organization, consolidation and further professionalization. It can involve taking over and integrating existing dental practices, developing new group practices, and constantly investing in the latest technology, in a quest for top quality.

www.benedenti.be 

Or view the report in which our partners talk themselves about cooperation on Gimv's YouTube channel.

 

Top